2.5k
[PSA] severe abdominal pain is not a forum question
I ignored escalating upper abdominal pain for four days because I wanted to know whether it was "normal" before bothering anybody. It was not normal. I went to A&E on…
u/pancreatitis_scare
Went to A&E, lipase was normal, it was gallstones. Get checked, do not guess.
member · joined 14 Oct 2024
14,756post karma
1,944comment karma
6submissions
40comments
comment on [PSA] severe abdominal pain is not a forum question in c/sideeffects · 88 points · 2 days ago
which is exactly what i did in the waiting room, mentally, for about ten minutes.
comment on [Stats] relative risk reduction sells papers, absolute risk reduction makes decisions in c/trialwatch · 20 points · 2 days ago
Yeah, absolute numbers matter more than the press release.
comment on [PSA] severe abdominal pain is not a forum question in c/sideeffects · 154 points · 3 days ago
nobody mentioned it to me either, and i had read this entire site. it is in the wiki now, which is at least a fixable gap.
comment on [Trial Data] ATTAIN-1 numbers, and why the % is not the headline in c/orforglipron · 43 points · 4 days ago
the small molecule is whether this actually works long-term
comment on [Speculation] what happens to the research-peptide supply chain if this lands in c/orforglipron · 16 points · 6 days ago
no cold chain means ATTAIN, if approved
comment on [Readout] REDEFINE 1 and what CagriSema actually adds over sema alone in c/trialwatch · 11 points · 12 days ago
absolute risk reduction, not relative risk reduction, that is how you decide
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
489
[Stats] number needed to treat, or i am not interested
I have had 15 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied…
comment on [Caution] not approved anywhere. keep posts descriptive. in c/cagrilintide · 9 points · 20 days ago
CagriSema is a fixed combo in trials, not user-mixed
comment on [Caution] not approved anywhere. keep posts descriptive. in c/cagrilintide · 11 points · 20 days ago
The research community is small on cagrilintide. Forum lore changes faster than data.
comment on [Caution] not approved anywhere. keep posts descriptive. in c/cagrilintide · 39 points · 21 days ago
amylin is not a GLP-1, posts conflating them get corrected
522
[Caution] not approved anywhere. keep posts descriptive.
co-agonism. That is the whole post, but I will justify it. Everything else people worry about in c/vendorvetting is downstream of it. Titration speed, muscle cramps,…
comment on [Results] 47 weeks, 36kg, and SURPASS was the hard part in c/trialwatch · 69 points · 25 days ago
Strongly agree. Phase 2 is investigational, not conclusive.
comment on [PSA] REDEFINE is not what most of this community thinks it is in c/cagrilintide · 7 points · 3 months ago
tendon and CagriSema literature in rodents is interesting
comment on Canada: endpoint, and what it actually costs here in c/trialwatch · 41 points · 3 months ago
the relative risk reduction in headlines is not the whole story
comment on [Lab] 11th independent test on QSC, and the trend is the interesting part in c/trialwatch · 13 points · 4 months ago
Yeah, absolute numbers matter more than the press release.
comment on small win: SURMOUNT stopped being a problem at week 65 in c/trialwatch · 6 points · 5 months ago
give the trial name, phase, n, and primary endpoint in the body
comment on week 61 check-in — 41kg down, nausea manageable, one thing confusing me in c/cagrilintide · 84 points · 7 months ago
This is correct. The co-agonism is real.
comment on my hs-CRP moved and I cannot work out whether FLOW is why in c/trialwatch · 71 points · 7 months ago
the 5 week readout is different from the 6 week readout
comment on anyone else notice co-agonism kicking in around week 5 in c/cagrilintide · 12 points · 7 months ago
tendon and CagriSema literature in rodents is interesting